Credit: Avani Anchalia Akhilesh Gururani #IndianPharma #GLP1 #Semaglutide #Research To view or add a comment, sign in GLP-1 Market: From Diabetes to a Multi-Billion Dollar Metabolic Empire GLP-1 therapies are redefining the future of metabolic disease treatment
Alpha Glow stands out by combining premium peptides with a moisturizing cream base designed for everyday use
Yes, and it's worth asking your provider about directly
Critical Safety Gaps for Mental Health Applications Unknown effects on cognitive function, memory, personality, mood stability beyond intended therapeutic effect Long-term impacts on brain chemistry (chronic administration effects unexplored beyond 6 weeks in animals) Potential for psychological dependence or tolerance (not studied systematically) Impacts on developing brains in adolescents and young adults (completely unknown with no pediatric studies) Drug Interactions Pose Serious Concerns BPC-157s simultaneous effects on serotonin, dopamine, GABA, glutamate, and nitric oxide systems create multiple theoretical interaction points with psychiatric medications, yet interactions are not well studied. Specific concerns include: With SSRIs and SNRIs: Risk of serotonin syndrome is genuine
Therefore, it is better to mainly reduce fat without significant reducing muscle mass when weight loss is achieved
It stimulates the production of collagen, elastin, and glycosaminoglycans (GAGs)